These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 24247174)
21. The role of combination medical therapy in benign prostatic hyperplasia. Greco KA; McVary KT Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123 [TBL] [Abstract][Full Text] [Related]
22. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat. Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674 [TBL] [Abstract][Full Text] [Related]
23. Survey on benign prostatic hyperplasia distribution and treatment patterns for men with lower urinary tract symptoms visiting urologists at general hospitals in Korea: a prospective, noncontrolled, observational cohort study. Lee SH; Chung BH; Kim CS; Lee HM; Kim CI; Yoo TK; Lee KS; Park KS; Byun SS; Yoon BI; Kim SW; Lee JY Urology; 2012 Jun; 79(6):1379-84. PubMed ID: 22503769 [TBL] [Abstract][Full Text] [Related]
29. Patient centred care for the medical treatment of lower urinary tract symptoms in patients with benign prostatic obstruction: a key point to improve patients' care - a systematic review. De Nunzio C; Presicce F; Lombardo R; Trucchi A; Bellangino M; Tubaro A; Moja E BMC Urol; 2018 Jun; 18(1):62. PubMed ID: 29940928 [TBL] [Abstract][Full Text] [Related]
30. A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Na R; Helfand BT; Chen H; Conran CA; Crawford SE; Hayward SW; Tammela TLJ; Hoffman-Bolton J; Zheng SL; Walsh PC; Schleutker J; Platz EA; Isaacs WB; Xu J Prostate; 2017 Aug; 77(11):1213-1220. PubMed ID: 28656603 [TBL] [Abstract][Full Text] [Related]
32. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function. Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205 [TBL] [Abstract][Full Text] [Related]
34. Risk factors for progression or improvement of lower urinary tract symptoms in a prospective cohort of men. Martin S; Lange K; Haren MT; Taylor AW; Wittert G; J Urol; 2014 Jan; 191(1):130-7. PubMed ID: 23770136 [TBL] [Abstract][Full Text] [Related]
35. Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction. Brock G; Broderick G; Roehrborn CG; Xu L; Wong D; Viktrup L BJU Int; 2013 Nov; 112(7):990-7. PubMed ID: 23937669 [TBL] [Abstract][Full Text] [Related]
36. Debilitating lower urinary tract symptoms in the post-renal transplant population can be predicted pretransplantation. Dion M; Cristea O; Langford S; Luke PP; Sener A Transplantation; 2013 Feb; 95(4):589-94. PubMed ID: 23263609 [TBL] [Abstract][Full Text] [Related]
37. Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia: therapeutic options for the man at risk. Emberton M; Zinner N; Michel MC; Gittelman M; Chung MK; Madersbacher S BJU Int; 2007 Aug; 100(2):249-53. PubMed ID: 17617135 [TBL] [Abstract][Full Text] [Related]
38. Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia. Gallegos PJ; Frazee LA Pharmacotherapy; 2008 Mar; 28(3):356-65. PubMed ID: 18294115 [TBL] [Abstract][Full Text] [Related]
39. Benign prostatic hyperplasia and lower urinary tract symptoms. A review of current evidence. Carrero-López VM; Cózar-Olmo JM; Miñana-López B Actas Urol Esp; 2016 Jun; 40(5):288-94. PubMed ID: 26823069 [TBL] [Abstract][Full Text] [Related]
40. Benign prostatic hyperplasia and lower urinary tract symptoms: evidence and approaches for best case management. Barkin J Can J Urol; 2011 Apr; 18 Suppl():14-9. PubMed ID: 21501546 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]